Abnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies

被引:19
作者
Anders, Sherry
Kinney, Dennis K. [1 ,2 ]
机构
[1] McLean Hosp, Belmont, MA 02178 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
关键词
Schizophrenia; Development; Hypothesis; Immune system; Infection; PITUITARY-ADRENAL AXIS; STRESSFUL LIFE EVENTS; VITAMIN-D DEFICIENCY; INDUCED MICROGLIAL ACTIVATION; ENVIRONMENTAL RISK-FACTORS; VARIANTS CONFERRING RISK; EPSTEIN-BARR-VIRUS; AUTOIMMUNE-DISEASES; PSYCHOSOCIAL STRESS; PRENATAL INFECTION;
D O I
10.1016/j.brainres.2015.02.043
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Extensive research implicates disturbed immune function and development in the etiology and pathology of schizophrenia. In addition to reviewing evidence for immunological factors in schizophrenia, this paper discusses how an emerging model of atypical immune function and development helps explain a wide variety of well-established - but puzzling findings about schizophrenia. A number of theorists have presented hypotheses that early immune system programming, disrupted by pre- and perinatal adversity, often combines with abnormal brain development to produce schizophrenia. The present paper focuses on the hypothesis that disruption of early immune system development produces a latent immune vulnerability that manifests more fully after puberty, when changes in immune function and the thymus leave individuals more susceptible to infections and immune dysfunctions that contribute to schizophrenia. Complementing neurodevelopmental models, this hypothesis integrates findings on many contributing factors to schizophrenia, including prenatal adversity, genes, climate, migration, infections, and stress, among others. It helps explain, for example, why (a) schizophrenia onset is typically delayed until years after prenatal adversity, (b) individual risk factors alone often do not lead to schizophrenia, and (c) schizophrenia prevalence rates actually tend to be higher in economically advantaged countries. Here we discuss how the hypothesis explains 10 key findings, and suggests new, potentially highly cost-effective, strategies for treatment and prevention of schizophrenia. Moreover, while most human research linking immune factors to schizophrenia has been correlational, these strategies provide ethical ways to experimentally test in humans theories about immune function and schizophrenia. This article is part of a Special Issue entitled SI: Neuroimmunology in Health And Disease. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 112
页数:20
相关论文
共 225 条
[1]   DEPRESSED NATURAL-KILLER-CELL ACTIVITY IN SCHIZOPHRENIC-PATIENTS [J].
ABDELJABER, MH ;
NAIR, MPN ;
SCHORK, MA ;
SCHWARTZ, SA .
IMMUNOLOGICAL INVESTIGATIONS, 1994, 23 (4-5) :259-268
[2]   Childhood meningitis increases the risk for adult schizophrenia [J].
Abrahao, AL ;
Focaccia, R ;
Gattaz, WF .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2005, 6 :44-48
[3]   Vitamin D in defense of the human immune response [J].
Adams, Johns S. ;
Liu, Philip T. ;
Chun, Rene ;
Modlin, Robert L. ;
Hewison, Martin .
SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES, 2007, 1117 :94-105
[4]   Sex differences in the risk of schizophrenia - Evidence from meta-analysis [J].
Aleman, A ;
Kahn, RS ;
Selten, JP .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (06) :565-571
[5]   Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology [J].
Altamura, A. Carlo ;
Pozzoli, Sara ;
Fiorentini, Alessio ;
Dell'Osso, Bernardo .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 :63-70
[6]   Using histamine (H1) antagonists, in particular atypical anti psychotics, to treat anemia of chronic disease via interieukin-6 suppression [J].
Altschuler, EL ;
Kast, RE .
MEDICAL HYPOTHESES, 2005, 65 (01) :65-67
[7]   Non-antibiotics: Alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries [J].
Amaral, Leonard ;
Viveiros, Miguel ;
Kristiansen, Jette E. .
CURRENT DRUG TARGETS, 2006, 7 (07) :887-891
[8]   Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression [J].
Anderson, George ;
Maes, Michael .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 :5-19
[9]  
[Anonymous], EXPERT OPIN PHARMACO
[10]  
[Anonymous], INT J NEUROPSYCHOPHA